7 alpha-hydroxy-4-cholesten-3-one has been researched along with elobixibat in 2 studies
| Studies (7 alpha-hydroxy-4-cholesten-3-one) | Trials (7 alpha-hydroxy-4-cholesten-3-one) | Recent Studies (post-2010) (7 alpha-hydroxy-4-cholesten-3-one) | Studies (elobixibat) | Trials (elobixibat) | Recent Studies (post-2010) (elobixibat) |
|---|---|---|---|---|---|
| 134 | 28 | 59 | 35 | 9 | 34 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camilleri, M; Graffner, H; Holst, JJ; Rikner, L; Rudling, M | 1 |
| Amano, H; Furuie, H; Kumagai, Y; Maeda, M; Nakagawa, C; Oikawa, I; Sasaki, Y | 1 |
2 trial(s) available for 7 alpha-hydroxy-4-cholesten-3-one and elobixibat
| Article | Year |
|---|---|
Specific inhibition of bile acid transport alters plasma lipids and GLP-1.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bile Acids and Salts; Cholestenones; Cholesterol, HDL; Cholesterol, LDL; Chronic Disease; Constipation; Dipeptides; Dyslipidemias; Female; Glucagon-Like Peptide 1; Humans; Lipids; Male; Middle Aged; Thiazepines; Triglycerides; Young Adult | 2015 |
Effect of single and multiple doses of elobixibat, an ileal bile acid transporter inhibitor, on chronic constipation: A randomized controlled trial.
Topics: Administration, Oral; Adult; Carrier Proteins; Cholestenones; Cholesterol, LDL; Chronic Disease; Constipation; Cross-Over Studies; Defecation; Dipeptides; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Food-Drug Interactions; Humans; Ileum; Male; Membrane Glycoproteins; Middle Aged; Placebos; Sex Factors; Tablets; Thiazepines; Treatment Outcome; Young Adult | 2018 |